Pseudorabies virus as vaccine vectors for delivering foreign antigens: methodology and application

Pseudorabies virus (PRV) is the etiological agent of pseudorabies (PR). It belongs to the Herpesviridae family and has double-stranded linear DNA encoding more than 70 proteins. Many of these proteins are non-essential for viral replication and provide insertion sites for foreign genes to enable heterologous protein expression. PRV is a promising viral-vector platform for expressing foreign proteins and developing vaccines against multiple pathogens. However, no recombinant PRV-vectored vaccines are commercially available to date. Here, we summarize the biological characteristics of PRV, recombinant PRV construction methodology, foreign gene insertion sites and optimization, immune responses, and applications of recombinant PRV-vectored vaccines. This study provides insights into the development of PRV recombinant vaccines and the latest research progress, offering novel perspectives for advancing preventive medicine through vaccinology.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-10-29
DOI
https://doi.org/10.3389/fimmu.2026.1997723
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pseudorabies virus as vaccine vectors for delivering foreign antigens: methodology and application

Tongqing An, Yong-Bo Yang, Xiaoxiao Tian
Frontiers in Immunology
Animal Virus Infections Studies
article

Pseudorabies virus as vaccine vectors for delivering foreign antigens: methodology and application

Tongqing An, Yong-Bo Yang, Xiaoxiao Tian
article en

Abstract

Pseudorabies virus (PRV) is the etiological agent of pseudorabies (PR). It belongs to the Herpesviridae family and has double-stranded linear DNA encoding more than 70 proteins. Many of these proteins are non-essential for viral replication and provide insertion sites for foreign genes to enable heterologous protein expression. PRV is a promising viral-vector platform for expressing foreign proteins and developing vaccines against multiple pathogens. However, no recombinant PRV-vectored vaccines are commercially available to date. Here, we summarize the biological characteristics of PRV, recombinant PRV construction methodology, foreign gene insertion sites and optimization, immune responses, and applications of recombinant PRV-vectored vaccines. This study provides insights into the development of PRV recombinant vaccines and the latest research progress, offering novel perspectives for advancing preventive medicine through vaccinology.

Frontiers in ImmunologyVol. 17
Chinese Academy of Agricultural Sciences (CN), China Animal Health and Epidemiology Center (CN), Harbin Veterinary Research Institute (CN)
National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province
Good health and well-being
Openalex Percentile: Top 15%
Animal Virus Infections Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon